•
Jun 30, 2022

iTeos Therapeutics Q2 2022 Earnings Report

Total Revenue
$41.7M
EPS
$0.15
Previous year: -$0.75
-120.0%
Gross Profit
$41.5M
Cash and Equivalents
$792M
Previous year: $303M
+161.4%
Free Cash Flow
-$30.8M
Previous year: -$18.7M
+65.3%
Total Assets
$815M
Previous year: $319M
+155.7%

iTeos Therapeutics

iTeos Therapeutics